A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- Colombia, a month of unusual strikes to shed the country’s skin May 30, 2021
- Ignacio López Tarso left the hospital after being hospitalized for pneumonia Jun 4, 2022
- Belen Rodriguez in the storm: special treatment at the hospital? Jul 15, 2021
- 19 surgeries are suspended at the Regional Hospital during the first day of the Fenats stoppage Nov 9, 2022
- Covid, WHO: infections in the world increase, Delta variant in 148 countries Aug 18, 2021
- Called vitamin, that can protect from vertigo Aug 9, 2020
- There is a deficit of 200 million pesos for covid care Sep 14, 2021